| |
| |
|
| Insider
Information: |
Parshall B Lynne |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,619,493 |
|
|
Indirect Shares
|
7,049,500 |
|
|
| Direct
Value |
$16,734,476 |
|
|
|
Indirect Value
|
$16,143,355 |
|
|
| Total
Shares |
12,668,993 |
|
|
| Total
Value |
$32,877,831 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -84.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-12-28 |
82,588 |
2016-12-15 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2024-05-15 |
20,600 |
2020-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-09-26 |
4 |
AS |
$7.04 |
$17,598 |
D/D |
(2,500) |
6,941,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-01 |
4 |
AS |
$6.71 |
$21,808 |
D/D |
(3,250) |
6,938,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-02 |
4 |
AS |
$6.64 |
$24,903 |
D/D |
(3,750) |
6,934,250 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-03 |
4 |
AS |
$6.88 |
$22,688 |
D/D |
(3,300) |
6,930,950 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-08 |
4 |
AS |
$6.63 |
$21,888 |
D/D |
(3,300) |
6,927,650 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-09 |
4 |
AS |
$6.58 |
$31,238 |
D/D |
(4,750) |
6,922,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-10 |
4 |
AS |
$6.41 |
$12,813 |
D/D |
(2,000) |
6,920,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-15 |
4 |
AS |
$6.67 |
$28,687 |
D/D |
(4,300) |
6,916,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-16 |
4 |
AS |
$6.76 |
$32,450 |
D/D |
(4,800) |
6,911,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-17 |
4 |
AS |
$6.79 |
$20,371 |
D/D |
(3,000) |
6,908,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-22 |
4 |
AS |
$14.00 |
$1,533,125 |
D/D |
(109,534) |
6,799,266 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-23 |
4 |
AS |
$14.24 |
$24,202 |
D/D |
(1,700) |
6,797,566 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2014-10-24 |
4 |
AS |
$15.19 |
$28,109 |
D/D |
(1,850) |
6,795,716 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2014-10-30 |
4 |
AS |
$45.12 |
$499,535 |
D/D |
(11,071) |
4,306 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2014-10-30 |
4 |
OE |
$7.25 |
$98,939 |
D/D |
11,071 |
12,867 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • – |
2014-11-03 |
4 |
S |
$15.94 |
$20,390,613 |
D/D |
(1,279,411) |
5,516,305 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-01-01 |
4 |
A |
$30.05 |
$3,335 |
D/D |
111 |
4,417 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-01-02 |
4 |
AS |
$62.12 |
$695,688 |
D/D |
(11,200) |
4,417 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-01-02 |
4 |
OE |
$14.69 |
$164,528 |
D/D |
11,200 |
15,617 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,748 |
9,890 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-01-16 |
4 |
S |
$67.96 |
$278,177 |
D/D |
(4,093) |
8,072 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-04-01 |
4 |
OE |
$14.69 |
$78,988 |
D/D |
5,377 |
13,449 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-04-01 |
4 |
AS |
$61.93 |
$333,009 |
D/D |
(5,377) |
8,072 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-04-07 |
4 |
OE |
$14.69 |
$81,750 |
D/D |
5,565 |
13,637 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & Secretary |
• • – |
2015-04-07 |
4 |
AS |
$63.07 |
$350,990 |
D/D |
(5,565) |
8,072 |
0 |
- |
|
304 Records found
|
|
Page 9 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
